ロード中...
Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
BACKGROUND: The last decade has seen the increasing use of biological medicines in combination with chemotherapy containing 5-fluorouracil/oxaliplatin or irinotecan for the treatment of metastatic colorectal cancer (mCRC). These combinations have resulted in increased progression-free survival (PFS)...
保存先:
| 出版年: | BioDrugs |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6290722/ https://ncbi.nlm.nih.gov/pubmed/30499082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0322-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|